SJR 60·AL·senate
Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings
In CommitteeFiled Feb 25, 2026
Sponsor: Givhan
Latest Action
Pending Committee Action in House of Origin
Feb 25, 2026
Summary
The resolution asks the Alabama Medicaid Agency to evaluate the overall expenses and possible savings of covering GLP‑1 medications for weight management, and to share its analysis with the Legislature. It focuses on roughly 110,000 Medicaid adults and children who could qualify, aiming to inform future coverage decisions and improve health outcomes.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SJR 60 changes status, plus AI-powered summaries and stage predictions.
Sign up free